Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
2.
Cell ; 139(6): 1069-83, 2009 Dec 11.
Artículo en Inglés | MEDLINE | ID: mdl-19962179

RESUMEN

Chromosomal translocations are a hallmark of leukemia/lymphoma and also appear in solid tumors, but the underlying mechanism remains elusive. By establishing a cellular model that mimics the relative frequency of authentic translocation events without proliferation selection, we report mechanisms of nuclear receptor-dependent tumor translocations. Intronic binding of liganded androgen receptor (AR) first juxtaposes translocation loci by triggering intra- and interchromosomal interactions. AR then promotes site-specific DNA double-stranded breaks (DSBs) at translocation loci by recruiting two types of enzymatic activities induced by genotoxic stress and liganded AR, including activation-induced cytidine deaminase and the LINE-1 repeat-encoded ORF2 endonuclease. These enzymes synergistically generate site-selective DSBs at juxtaposed translocation loci that are ligated by nonhomologous end joining pathway for specific translocations. Our data suggest that the confluence of two parallel pathways initiated by liganded nuclear receptor and genotoxic stress underlies nonrandom tumor translocations, which may function in many types of tumors and pathological processes.


Asunto(s)
Neoplasias de la Próstata/genética , Receptores Androgénicos/metabolismo , Transcripción Genética , Translocación Genética , Línea Celular Tumoral , Daño del ADN , Reparación del ADN , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Humanos , Intrones , Elementos de Nucleótido Esparcido Largo , Masculino , Sistemas de Lectura Abierta , Serina Endopeptidasas/genética , Serina Endopeptidasas/metabolismo , Transactivadores/genética , Transactivadores/metabolismo , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Regulador Transcripcional ERG
3.
Am J Physiol Renal Physiol ; 297(5): F1330-41, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19726549

RESUMEN

Kidney organogenesis depends on reciprocal interactions between the ureteric bud (UB) and the metanephric mesenchyme (MM) to form the UB-derived collecting system and MM-derived nephron. With the advent of in vitro systems, it is clear that UB branching can occur independently of MM contact; however, little has been done to detail the role of MM cellular contact in this process. Here, a model system in which the cultured isolated UB is recombined with uninduced MM is used to isolate the effects of the MM progenitor tissue on the development and maturation of the collecting system. By morphometrics, we demonstrate that cellular contact with the MM is required for vectorial elongation of stalks and tapering of luminal caliber of UB-derived tubules. Expression analysis of developmentally significant genes indicates the cocultured tissue is most similar to an embryonic day 19 (E19) kidney. The likely major contributor to this is the functional maturation of the collecting duct and proximal nephron segments in the UB-induced MM, as measured by quantitative PCR, of the collecting duct-specific arginine vasopressin receptor and the nephron tubule segment-specific organic anion transporter OAT1, Na-P(i) type 2 cotransporter, and Tamm-Horsfall protein gene expressions. However, expression of aquaporin-2 is upregulated similarly in isolated UB and cocultured tissue, suggesting that some aspects of functional maturation can occur independently of MM cellular contact. In addition to its sculpting effects, the MM normalized a "branchless" UB morphology induced by FGF7 or heregulin in isolated UB culture. The morphological changes induced by the MM were accompanied by a reassignment of GFRalpha1 (a receptor for GDNF) to tips. Such "quality control" by the MM of UB morphology may provide resiliency to the branching program. This may help to explain a number of knockout phenotypes in which branching and/or cystic defects are less impressive than expected. A second hit in the MM may thus be necessary to make these defects fully apparent.


Asunto(s)
Riñón/embriología , Mesodermo/fisiología , Útero/anomalías , Útero/embriología , Animales , Técnicas de Cocultivo , ADN Complementario/biosíntesis , ADN Complementario/genética , Femenino , Colorantes Fluorescentes , Inmunohistoquímica , Riñón/anatomía & histología , Análisis por Micromatrices , Microinyecciones , Fenotipo , Embarazo , Ratas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Rodaminas , Útero/anatomía & histología
4.
Proc Natl Acad Sci U S A ; 105(49): 19199-204, 2008 12 09.
Artículo en Inglés | MEDLINE | ID: mdl-19052240

RESUMEN

Although the role of liganded nuclear receptors in mediating coactivator/corepressor exchange is well-established, little is known about the potential regulation of chromosomal organization in the 3-dimensional space of the nucleus in achieving integrated transcriptional responses to diverse signaling events. Here, we report that ligand induces rapid interchromosomal interactions among specific subsets of estrogen receptor alpha-bound transcription units, with a dramatic reorganization of nuclear territories, which depends on the actions of nuclear actin/myosin-I machinery and dynein light chain 1. The histone lysine demethylase, LSD1, is required for these ligand-induced interactive loci to associate with distinct interchromatin granules, long thought to serve as "storage" sites for the splicing machinery, some critical transcription elongation factors, and various chromatin remodeling complexes. We demonstrate that this 2-step nuclear rearrangement is essential for achieving enhanced, coordinated transcription of nuclear receptor target genes.


Asunto(s)
Células Epiteliales/fisiología , Redes Reguladoras de Genes/fisiología , Oxidorreductasas N-Desmetilantes/genética , Receptores Citoplasmáticos y Nucleares/genética , Transcripción Genética/fisiología , Neoplasias de la Mama , Línea Celular Tumoral , Núcleo Celular/fisiología , Cromatina/fisiología , Células Epiteliales/citología , Receptor alfa de Estrógeno/genética , Receptor alfa de Estrógeno/metabolismo , Estrógenos/metabolismo , Regulación de la Expresión Génica/fisiología , Histona Demetilasas , Humanos , Hibridación Fluorescente in Situ , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Oxidorreductasas N-Desmetilantes/química , Oxidorreductasas N-Desmetilantes/metabolismo , Estructura Terciaria de Proteína , Receptores Citoplasmáticos y Nucleares/metabolismo , Factor Trefoil-1 , Proteínas Supresoras de Tumor/genética , Proteínas Supresoras de Tumor/metabolismo
5.
Mol Cell ; 29(6): 755-66, 2008 Mar 28.
Artículo en Inglés | MEDLINE | ID: mdl-18374649

RESUMEN

A key strategy to achieve regulated gene expression in higher eukaryotes is to prevent illegitimate signal-independent activation by imposing robust control on the dismissal of corepressors. Here, we report that many signaling pathways, including Notch, NF-kappaB, and nuclear receptor ligands, are subjected to a dual-repression "checkpoint" based on distinct corepressor complexes. Gene activation requires the release of both CtBP1/2- and NCoR/SMRT-dependent repression, through the coordinate action of two highly related exchange factors, the transducer beta-like proteins TBL1 and TBLR1, that license ubiquitylation and degradation of CtBP1/2 and NCoR/SMRT, respectively. Intriguingly, their function and differential specificity reside in only five specific Ser/Thr phosphorylation site differences, regulated by direct phosphorylation at the level of the promoter, as exemplified by the role of PKCdelta in TBLR1-dependent dismissal of NCoR. Thus, our data reveal a strategy of dual-factor repression checkpoints, in which dedicated exchange factors serve as sensors for signal-specific dismissal of distinct corepressors, with specificity imposed by upstream signaling pathways.


Asunto(s)
Oxidorreductasas de Alcohol/genética , Proteínas de Unión al ADN/genética , Proteínas Nucleares/metabolismo , Regiones Promotoras Genéticas , Receptores Citoplasmáticos y Nucleares/metabolismo , Proteínas Represoras/metabolismo , Transcripción Genética , Transducina/metabolismo , Animales , Neoplasias de la Mama , Línea Celular , Línea Celular Tumoral , Femenino , Regulación Neoplásica de la Expresión Génica , Genes Reporteros , Humanos , Co-Represor 2 de Receptor Nuclear , Complejo de la Endopetidasa Proteasomal/metabolismo , Proteínas Represoras/genética , Activación Transcripcional , Ubiquitina/metabolismo
6.
Cell ; 132(6): 996-1010, 2008 Mar 21.
Artículo en Inglés | MEDLINE | ID: mdl-18358812

RESUMEN

While the transcriptional machinery has been extensively dissected at the molecular level, little is known about regulation of chromosomal organization in the three-dimensional space of the nucleus to achieve integrated transcriptional responses to diverse signaling events. Here, we report that ligand induces rapid interchromosomal interactions among subsets of estrogen receptor alpha-bound transcription units, with a dramatic reorganization of nuclear territories requiring nuclear actin/myosin-I transport machinery, dynein light chain 1 (DLC1), and a specific subset of transcriptional coactivators and chromatin remodeling complexes. We establish a requirement for the histone lysine demethylase, LSD1, in directing specific interchromosomal interaction loci to distinct interchromatin granules, long thought to be "storage" sites for splicing machinery, and demonstrate that these three-dimensional motor-dependent interactions are required to achieve enhanced transcription of specific estrogen-receptor target genes. These findings reveal roles for the modulation of nuclear architecture in orchestrating regulated gene-expression programs in the mammalian nucleus.


Asunto(s)
Cromatina/metabolismo , Receptor alfa de Estrógeno/metabolismo , Redes Reguladoras de Genes , Proteínas Motoras Moleculares/metabolismo , Oxidorreductasas N-Desmetilantes/metabolismo , Actinas/metabolismo , Línea Celular Tumoral , Núcleo Celular , Células Cultivadas , Histona Demetilasas , Humanos , Cuerpos de Inclusión Intranucleares/metabolismo , Transcripción Genética
7.
Cell Cycle ; 6(13): 1594-604, 2007 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-17525531

RESUMEN

The molecular mechanisms that control the proliferation and differentiation of specific cell types remain poorly understood. Positive ETS factors play important roles in mediating proliferative responses to Ras/MAPK signaling in many cell types following mitogenic stimulation. PE-1/METS, a member of the ETS-domain family transcription factors that functions as a transcriptional repressor, can block mitogenic responses mediated by positively acting Ets factors. The anti-proliferative functions of PE-1/METS require its interaction with DP103, a multifunctional DEAD-box protein that mediates interactions with corepressor proteins and acts in a cooperative manner with Rb family members and to repress cell cycle control genes. ETS-2 repressor factor (ERF) is structurally related to and also functions as a transcriptional repressor, but endogenous target genes and mechanisms of repression remain unknown. Here, we demonstrate that like PE-1/METS, ERF-mediated repression also requires DP103, and that ERF negatively regulates the c-myc and cdc2 genes. In contrast to PE-1/METS, however, ERF-mediated repression of these genes is inactivated by MAPK signaling through phosphorylation sites that are ERF-specific. Furthermore, constitutive activation of the Ras/MAPK pathway in RAW 264.7 cells transformed by the v-Abelson leukemia virus is associated with constitutive inactivation of ERF in this cell type. We propose that ERF and PE-1/METS function to impose 'repression checkpoints' on a subset of cell cycle control genes that are differentially regulated by growth factor signaling pathways that control proliferation and differentiation and that ERF is targeted for inactivation by transforming oncogenes such as vAbl.


Asunto(s)
Proteína Quinasa CDC2/genética , Proteínas de Unión al ADN/fisiología , Regulación hacia Abajo , Genes myc , Proteínas Proto-Oncogénicas c-ets/fisiología , Proteínas Represoras/fisiología , Factores de Transcripción/fisiología , Animales , Células Cultivadas , Proteína 20 DEAD-Box , ARN Helicasas DEAD-box/química , ARN Helicasas DEAD-box/metabolismo , Proteínas de Unión al ADN/metabolismo , Expresión Génica/efectos de los fármacos , Humanos , Péptidos y Proteínas de Señalización Intercelular/farmacología , Modelos Biológicos , Proteínas Oncogénicas v-abl/fisiología , Regiones Promotoras Genéticas , Unión Proteica , Estructura Terciaria de Proteína , Proteínas Proto-Oncogénicas c-ets/metabolismo , Ratas , Proteínas Represoras/metabolismo , Factores de Transcripción/metabolismo
8.
Cell ; 128(3): 505-518, 2007 Feb 09.
Artículo en Inglés | MEDLINE | ID: mdl-17289570

RESUMEN

Nuclear receptors undergo ligand-dependent conformational changes that are required for corepressor-coactivator exchange, but whether there is an actual requirement for specific epigenetic landmarks to impose ligand dependency for gene activation remains unknown. Here we report an unexpected and general strategy that is based on the requirement for specific cohorts of inhibitory histone methyltransferases (HMTs) to impose gene-specific gatekeeper functions that prevent unliganded nuclear receptors and other classes of regulated transcription factors from binding to their target gene promoters and causing constitutive gene activation in the absence of stimulating signals. This strategy, based at least in part on an HMT-dependent inhibitory histone code, imposes a requirement for specific histone demethylases, including LSD1, to permit ligand- and signal-dependent activation of regulated gene expression. These events link an inhibitory methylation component of the histone code to a broadly used strategy that circumvents pathological constitutive gene induction by physiologically regulated transcription factors.


Asunto(s)
Receptor alfa de Estrógeno/metabolismo , Regulación de la Expresión Génica , Histonas/metabolismo , Oxidorreductasas N-Desmetilantes/metabolismo , Línea Celular Tumoral , Inmunoprecipitación de Cromatina , Estradiol/metabolismo , Genoma Humano , Código de Histonas , Histona Demetilasas , N-Metiltransferasa de Histona-Lisina/genética , N-Metiltransferasa de Histona-Lisina/metabolismo , Humanos , Ligandos , Metilación , Regiones Promotoras Genéticas , Activación Transcripcional
9.
J Biol Chem ; 282(11): 8424-34, 2007 Mar 16.
Artículo en Inglés | MEDLINE | ID: mdl-17192276

RESUMEN

Maintenance of the cells of the vessel wall in a quiescent state is an important aspect of normal vascular physiology. Transcriptional repressors are widely believed to regulate this process, yet the exact factors involved and the mechanism of repression are not known. Here, we report that the POU domain transcription factor Oct-1 represses the expression of E-selectin and vascular cell adhesion molecule (VCAM-1), two cytokine-inducible, NF-kappaB-dependent endothelial-leukocyte adhesion molecules that participate in the leukocyte recruitment phase of the inflammatory response. Co-transfection and microinjection studies demonstrate that Oct-1 blocks tumor necrosis factor alpha-stimulated E-selectin and VCAM-1 expression. Gene expression arrays indicate that control of tumor necrosis factor alpha-induced, NF-kappaB-dependent gene expression by Oct-1 is promoter-specific. A DNA-binding mutant of Oct-1 represses NF-kappaB-dependent reporter gene expression. Biochemically, Oct-1 interacts with p65, suggesting that Oct-1 is involved in the regulation of NF-kappaB transactivation function. NF-kappaB-dependent gene expression is more pronounced in Oct-1-deficient than in wild-type murine embryonic fibroblasts, and reintroduction of human Oct-1 abolishes these differences. Finally, the cytokine interleukin-6 induces Oct-1 gene expression, providing a biologically relevant means by which NF-kappaB-dependent gene expression can be selectively reverted by Oct-1 to quiescent levels.


Asunto(s)
Regulación de la Expresión Génica , Interleucina-6/metabolismo , FN-kappa B/metabolismo , Factor 1 de Transcripción de Unión a Octámeros/fisiología , Células 3T3 , Animales , Células COS , Chlorocebus aethiops , Selectina E/metabolismo , Humanos , Ratones , Factor 1 de Transcripción de Unión a Octámeros/metabolismo , Estructura Terciaria de Proteína , Factor de Necrosis Tumoral alfa/metabolismo , Venas Umbilicales/metabolismo , Molécula 1 de Adhesión Celular Vascular/biosíntesis
10.
Science ; 312(5781): 1798-802, 2006 Jun 23.
Artículo en Inglés | MEDLINE | ID: mdl-16794079

RESUMEN

Multiple enzymatic activities are required for transcriptional initiation. The enzyme DNA topoisomerase II associates with gene promoter regions and can generate breaks in double-stranded DNA (dsDNA). Therefore, it is of interest to know whether this enzyme is critical for regulated gene activation. We report that the signal-dependent activation of gene transcription by nuclear receptors and other classes of DNA binding transcription factors, including activating protein 1, requires DNA topoisomerase IIbeta-dependent, transient, site-specific dsDNA break formation. Subsequent to the break, poly(adenosine diphosphate-ribose) polymerase-1 enzymatic activity is induced, which is required for a nucleosome-specific histone H1-high-mobility group B exchange event and for local changes of chromatin architecture. Our data mechanistically link DNA topoisomerase IIbeta-dependent dsDNA breaks and the components of the DNA damage and repair machinery in regulated gene transcription.


Asunto(s)
ADN-Topoisomerasas de Tipo II/metabolismo , Proteínas de Unión al ADN/metabolismo , ADN/metabolismo , Transcripción Genética , Activación Transcripcional , Línea Celular Tumoral , Cromatina/metabolismo , Inmunoprecipitación de Cromatina , Daño del ADN , Reparación del ADN , Proteínas de Unión al ADN/antagonistas & inhibidores , Inhibidores Enzimáticos/farmacología , Estradiol/farmacología , Receptor alfa de Estrógeno/metabolismo , Histonas/metabolismo , Humanos , Proteínas de la Membrana/genética , Nucleosomas/metabolismo , Poli(ADP-Ribosa) Polimerasa-1 , Poli(ADP-Ribosa) Polimerasas/metabolismo , Presenilina-2 , Regiones Promotoras Genéticas , Elementos de Respuesta , Tiobarbitúricos/farmacología , Inhibidores de Topoisomerasa II , Factores de Transcripción/metabolismo , Transfección
11.
Proc Natl Acad Sci U S A ; 103(9): 3100-5, 2006 Feb 28.
Artículo en Inglés | MEDLINE | ID: mdl-16492776

RESUMEN

The androgen receptor not only mediates prostate development but also serves as a key regulator of primary prostatic cancer growth. Although initially responsive to selective androgen receptor modulators (SARMs), which cause recruitment of the nuclear receptor-corepressor (N-CoR) complex, resistance invariably occurs, perhaps in response to inflammatory signals. Here we report that dismissal of nuclear receptor-corepressor complexes by specific signals or androgen receptor overexpression results in recruitment of many of the cohorts of coactivator complexes that permits SARMs and natural ligands to function as agonists. SARM-bound androgen receptors appear to exhibit failure to recruit specific components of the coactivators generally bound by liganded nuclear receptors, including cAMP response element-binding protein (CBP)/p300 or coactivator-associated arginine methyltransferase 1 (CARM1) to the SARM-bound androgen receptor, although still causing transcriptional activation of androgen receptor target genes. SARM-bound androgen receptors use distinct LXXLL (L, leucine; X, any amino acid) helices in the p160 nuclear receptor interaction domains that may impose selective allosteric effects, providing a component of the molecular basis of differential responses to different classes of ligands by androgen receptor.


Asunto(s)
Receptores Androgénicos/metabolismo , Regulación Alostérica , Antagonistas de Receptores Androgénicos , Andrógenos , Animales , Línea Celular Tumoral , Dihidrotestosterona/farmacología , Activación Enzimática , Humanos , Interleucina-1/farmacología , Ligandos , Masculino , Regiones Promotoras Genéticas/genética , Proteína-Arginina N-Metiltransferasas/genética , Proteína-Arginina N-Metiltransferasas/metabolismo , Receptores Androgénicos/genética , Factores de Transcripción p300-CBP/genética , Factores de Transcripción p300-CBP/metabolismo
12.
Cell ; 124(3): 615-29, 2006 Feb 10.
Artículo en Inglés | MEDLINE | ID: mdl-16469706

RESUMEN

Defining the precise molecular strategies that coordinate patterns of transcriptional responses to specific signals is central for understanding normal development and homeostasis as well as the pathogenesis of hormone-dependent cancers. Here we report specific prostate cancer cell/macrophage interactions that mediate a switch in function of selective androgen receptor antagonists/modulators (SARMs) from repression to activation in vivo. This is based on an evolutionarily conserved receptor N-terminal L/HX7LL motif, selectively present in sex steroid receptors, that causes recruitment of TAB2 as a component of an N-CoR corepressor complex. TAB2 acts as a sensor for inflammatory signals by serving as a molecular beacon for recruitment of MEKK1, which in turn mediates dismissal of the N-CoR/HDAC complex and permits derepression of androgen and estrogen receptor target genes. Surprisingly, this conserved sensor strategy may have arisen to mediate reversal of sex steroid-dependent repression of a limited cohort of target genes in response to inflammatory signals, linking inflammatory and nuclear receptor ligand responses to essential reproductive functions.


Asunto(s)
Macrófagos/metabolismo , Neoplasias de la Próstata/metabolismo , Receptores de Esteroides/metabolismo , Secuencia de Aminoácidos , Antagonistas de Andrógenos/metabolismo , Antagonistas de Andrógenos/farmacología , Animales , Comunicación Celular , Línea Celular , Resistencia a Antineoplásicos , Humanos , Técnicas In Vitro , Interleucina-1/farmacología , Macrófagos/patología , Masculino , Ratones , Modelos Biológicos , Neoplasias Hormono-Dependientes/tratamiento farmacológico , Neoplasias Hormono-Dependientes/metabolismo , Neoplasias Hormono-Dependientes/patología , Neoplasias de la Próstata/tratamiento farmacológico , Neoplasias de la Próstata/patología , Receptores de Esteroides/genética , Transducción de Señal
13.
Mol Cell Biol ; 26(4): 1386-97, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16449650

RESUMEN

The transcriptional corepressor mSin3 is associated with histone deacetylases (HDACs) and is utilized by many DNA-binding transcriptional repressors. We have cloned and characterized a novel mSin3A-binding protein, SAP25. SAP25 binds to the PAH1 domain of mSin3A, associates with the mSin3A-HDAC complex in vivo, and represses transcription when tethered to DNA. SAP25 is required for mSin3A-mediated, but not N-CoR-mediated, repression. SAP25 is a nucleocytoplasmic shuttling protein, actively exported from the nucleus by a CRM1-dependent mechanism. A fraction of SAP25 is located in promyelocytic leukemia protein (PML) nuclear bodies, and PML induces a striking nuclear accumulation of SAP25. An isotope-coded affinity tag quantitative proteomic analysis of the SAP25 complex revealed that SAP25 is associated with several components of the mSin3 complex, nuclear export machinery, and regulators of transcription and cell cycle. These results suggest that SAP25 is a novel core component of the mSin3 corepressor complex whose subcellular location is regulated by PML.


Asunto(s)
Proteínas Portadoras/química , Proteínas Portadoras/metabolismo , Histona Desacetilasas/química , Histona Desacetilasas/metabolismo , Transporte Activo de Núcleo Celular , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Animales , Células 3T3 BALB , Proteínas Portadoras/genética , Línea Celular , Clonación Molecular , Células HeLa , Histona Desacetilasas/genética , Humanos , Técnicas In Vitro , Ratones , Datos de Secuencia Molecular , Complejos Multiproteicos , Ratas , Proteínas Represoras/química , Proteínas Represoras/genética , Proteínas Represoras/metabolismo , Complejo Correpresor Histona Desacetilasa y Sin3
14.
Nature ; 437(7059): 759-63, 2005 Sep 29.
Artículo en Inglés | MEDLINE | ID: mdl-16127449

RESUMEN

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) has essential roles in adipogenesis and glucose homeostasis, and is a molecular target of insulin-sensitizing drugs. Although the ability of PPAR-gamma agonists to antagonize inflammatory responses by transrepression of nuclear factor kappa B (NF-kappaB) target genes is linked to antidiabetic and antiatherogenic actions, the mechanisms remain poorly understood. Here we report the identification of a molecular pathway by which PPAR-gamma represses the transcriptional activation of inflammatory response genes in mouse macrophages. The initial step of this pathway involves ligand-dependent SUMOylation of the PPAR-gamma ligand-binding domain, which targets PPAR-gamma to nuclear receptor corepressor (NCoR)-histone deacetylase-3 (HDAC3) complexes on inflammatory gene promoters. This in turn prevents recruitment of the ubiquitylation/19S proteosome machinery that normally mediates the signal-dependent removal of corepressor complexes required for gene activation. As a result, NCoR complexes are not cleared from the promoter and target genes are maintained in a repressed state. This mechanism provides an explanation for how an agonist-bound nuclear receptor can be converted from an activator of transcription to a promoter-specific repressor of NF-kappaB target genes that regulate immunity and homeostasis.


Asunto(s)
Regulación hacia Abajo , Inflamación/genética , PPAR gamma/metabolismo , Proteínas Represoras/metabolismo , Proteína SUMO-1/metabolismo , Animales , Células Cultivadas , Regulación hacia Abajo/efectos de los fármacos , Histona Desacetilasas/metabolismo , Ligandos , Lipopolisacáridos/farmacología , Macrófagos/metabolismo , Ratones , Complejos Multiproteicos/metabolismo , FN-kappa B/metabolismo , Óxido Nítrico Sintasa/genética , Óxido Nítrico Sintasa de Tipo II , Proteínas Nucleares/metabolismo , Co-Represor 1 de Receptor Nuclear , Unión Proteica/efectos de los fármacos , Proteínas Inhibidoras de STAT Activados , Proteínas/metabolismo
15.
Nature ; 434(7035): 921-6, 2005 Apr 14.
Artículo en Inglés | MEDLINE | ID: mdl-15829968

RESUMEN

Defining the molecular strategies that integrate diverse signalling pathways in the expression of specific gene programmes that are critical in homeostasis and disease remains a central issue in biology. This is particularly pertinent in cancer biology because downregulation of tumour metastasis suppressor genes is a common occurrence, and the underlying molecular mechanisms are not well established. Here we report that the downregulation of a metastasis suppressor gene, KAI1, in prostate cancer cells involves the inhibitory actions of beta-catenin, along with a reptin chromatin remodelling complex. This inhibitory function of beta-catenin-reptin requires both increased beta-catenin expression and recruitment of histone deacetylase activity. The coordinated actions of beta-catenin-reptin components that mediate the repressive state serve to antagonize a Tip60 coactivator complex that is required for activation; the balance of these opposing complexes controls the expression of KAI1 and metastatic potential. The molecular mechanisms underlying the antagonistic regulation of beta-catenin-reptin and the Tip60 coactivator complexes for the metastasis suppressor gene, KAI1, are likely to be prototypic of a selective downregulation strategy for many genes, including a subset of NF-kappaB target genes.


Asunto(s)
Acetiltransferasas/metabolismo , Antígenos CD/genética , Proteínas del Citoesqueleto/metabolismo , Regulación Neoplásica de la Expresión Génica/genética , Glicoproteínas de Membrana/genética , Metástasis de la Neoplasia/genética , Neoplasias de la Próstata/genética , Proteínas Proto-Oncogénicas/genética , Transactivadores/metabolismo , Transcripción Genética/genética , Acetiltransferasas/genética , Animales , Línea Celular Tumoral , Ensamble y Desensamble de Cromatina , Colágeno , Regulación hacia Abajo/genética , Combinación de Medicamentos , Histona Acetiltransferasas , Humanos , Proteína Kangai-1 , Laminina , Lisina Acetiltransferasa 5 , Masculino , Ratones , FN-kappa B/metabolismo , Trasplante de Neoplasias , Regiones Promotoras Genéticas/genética , Neoplasias de la Próstata/metabolismo , Proteoglicanos , ARN Mensajero/genética , ARN Mensajero/metabolismo , beta Catenina
16.
J Biol Chem ; 279(52): 54620-8, 2004 Dec 24.
Artículo en Inglés | MEDLINE | ID: mdl-15485806

RESUMEN

The aryl hydrocarbon receptor nuclear translocator/hypoxia-inducible factor (ARNT/HIF-1 beta) mediates an organism's response to various environmental cues, including those to chemical carcinogens, such as 2,3,7,8-tetrachlorodibenzo-rho-dioxin (TCDD or dioxin), via its formation of a functional transcription factor with the ligand activated aryl hydrocarbon receptor (AHR). Similarly, tissue responses to hypoxia are largely mediated through the HIF-1 heterodimeric transcription factor, comprising hypoxia-inducible factor-1 alpha (HIF-1 alpha) and ARNT. The latter response is essential for a metabolic switch from oxidative phosphorylation to glycolytic anaerobic metabolism as well as for angiogenesis and has been implicated as necessary for growth in many solid tumors. In this report, we demonstrate that the thyroid hormone receptor/retinoblastoma-interacting protein 230 (TRIP230) interacts directly with ARNT and is essential for both hypoxic and TCDD-mediated transcriptional responses. We initially identified TRIP230 as an ARNT-interacting protein in a yeast two-hybrid assay screen. This interaction was confirmed in mammalian cell systems using co-immunoprecipitation and in mammalian two-hybrid assays. Furthermore, TRIP230 could be recorded at sites of activated transcription of either TCDD- or hypoxia-inducible genes in a stimulus-dependent fashion by chromatin immunoprecipitation analysis. Finally, using single-cell microinjection and RNA interference assays, we demonstrate that TRIP230 is indispensable for TCDD- and hypoxia-dependent gene transcription.


Asunto(s)
Proteínas de Unión al ADN/fisiología , Dioxinas/farmacología , Hipoxia/fisiopatología , Proteínas Nucleares/fisiología , Receptores de Hidrocarburo de Aril/fisiología , Factores de Transcripción/fisiología , Transcripción Genética , Animales , Translocador Nuclear del Receptor de Aril Hidrocarburo , Clonación Molecular , Proteínas del Citoesqueleto , Proteínas de Unión al ADN/genética , Interacciones Farmacológicas , Expresión Génica , Humanos , Subunidad alfa del Factor 1 Inducible por Hipoxia , Técnicas de Inmunoadsorción , Ratones , Proteínas Nucleares/genética , Dibenzodioxinas Policloradas/farmacología , Receptores de Hidrocarburo de Aril/genética , Saccharomyces cerevisiae , Factores de Transcripción/genética , Transcripción Genética/efectos de los fármacos , Transcripción Genética/fisiología , Técnicas del Sistema de Dos Híbridos
17.
Proc Natl Acad Sci U S A ; 101(40): 14461-6, 2004 Oct 05.
Artículo en Inglés | MEDLINE | ID: mdl-15452344

RESUMEN

The nuclear receptor corepressor (NCoR) and the related factor known as silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) are essential components of multiprotein complexes that mediate active repression by unliganded nuclear receptors. Recent studies suggest that NCoR and SMRT can interact with and exert repressive effects on several other classes of DNA-binding transcription factors, but the physiological importance of these interactions has not been established. Here, investigation of endogenous transcriptional programs regulated by NCoR in macrophages reveals that NCoR acts as a transcriptional checkpoint for activator protein (AP)-1-dependent gene networks that regulate diverse biological processes including inflammation, cell migration, and collagen catabolism, with loss of NCoR, resulting in derepression of AP-1 target genes. The NCoR corepressor complex imposes an active block of exchange of c-Jun for c-Jun/c-Fos heterodimers, with targeted deletion of the c-Jun locus, resulting in loss of NCoR complexes from AP-1 target genes under basal conditions. The checkpoint function of NCoR is relieved by signal-dependent phosphorylation of c-Jun, which directs removal of NCoR/HDAC3/TBL1/TBLR1 complexes through recruitment of a specific ubiquitylation complex, as a prerequisite to the default binding of c-Jun/c-Fos heterodimers and transcriptional activation. The requirement for a checkpoint function to achieve the appropriate dynamic range of transcriptional responses to inflammatory signals is likely to be used by other signal-dependent transcription factors that regulate diverse homeostatic and developmental processes.


Asunto(s)
Activación de Macrófagos/fisiología , Proteínas Nucleares/metabolismo , Proteínas Represoras/metabolismo , Factor de Transcripción AP-1/metabolismo , Animales , Células Cultivadas , Genes jun , Activación de Macrófagos/genética , Ratones , Ratones Noqueados , Modelos Biológicos , Proteínas Nucleares/deficiencia , Proteínas Nucleares/genética , Co-Represor 1 de Receptor Nuclear , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Proteínas Represoras/genética , Transducción de Señal , Factor de Transcripción AP-1/genética , Transcripción Genética , Transfección
18.
Cell ; 116(4): 511-26, 2004 Feb 20.
Artículo en Inglés | MEDLINE | ID: mdl-14980219

RESUMEN

The mechanisms that control the precisely regulated switch from gene repression to gene activation represent a central question in mammalian development. Here, we report that transcriptional activation mediated by liganded nuclear receptors unexpectedly requires the actions of two highly related F box/WD-40-containing factors, TBL1 and TBLR1, initially identified as components of an N-CoR corepressor complex. TBL1/TBLR1 serve as specific adaptors for the recruitment of the ubiquitin conjugating/19S proteasome complex, with TBLR1 selectively serving to mediate a required exchange of the nuclear receptor corepressors, N-CoR and SMRT, for coactivators upon ligand binding. Tbl1 gene deletion in embryonic stem cells severely impairs PPARgamma-induced adipogenic differentiation, indicating that TBL1 function is also biologically indispensable for specific nuclear receptor-mediated gene activation events. The role of TBLR1 and TBL1 in cofactor exchange appears to also operate for c-Jun and NFkappaB and is therefore likely to be prototypic of similar mechanisms for other signal-dependent transcription factors.


Asunto(s)
Núcleo Celular/metabolismo , Activación Transcripcional , Adipocitos/citología , Animales , Diferenciación Celular , Células Cultivadas , Cisteína Endopeptidasas/metabolismo , Embrión de Mamíferos/citología , Endotelio Vascular/citología , Eliminación de Gen , Vectores Genéticos , Ligandos , Ratones , Microscopía Fluorescente , Modelos Biológicos , Modelos Genéticos , Complejos Multienzimáticos/metabolismo , FN-kappa B/metabolismo , Neuronas/citología , Proteínas Nucleares/metabolismo , Pruebas de Precipitina , Complejo de la Endopetidasa Proteasomal , Unión Proteica , Proteínas Proto-Oncogénicas c-jun/metabolismo , ARN/química , Receptores Citoplasmáticos y Nucleares/metabolismo , Proteínas Represoras/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transducción de Señal , Células Madre/metabolismo , Factores de Transcripción/metabolismo , Transducina/metabolismo , Ubiquitina/metabolismo
19.
Proc Natl Acad Sci U S A ; 100(6): 3245-50, 2003 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-12629224

RESUMEN

Pitx2 is a bicoid-related homeodomain factor that is required for effective cell type-specific proliferation directly activating a specific growth-regulating gene cyclin D2. Here, we report that Pitx2, in response to the Wntbeta-catenin pathway and growth signals, also can regulate c-Myc and cyclin D1. Investigation of molecular mechanisms required for Pitx2-dependent proliferation, in these cases, further supports a nuclear role for beta-catenin in preventing the histone deacetylase 1-dependent inhibitory functions of several DNA-binding transcriptional repressors, potentially including E2F4p130 pocket protein inhibitory complex, as well as lymphoid enhancer factor 1 and Pitx2, by dismissal of histone deacetylase 1 and loss of its enzymatic activity. Thus, beta-catenin plays a signal-integrating role in Wnt- and growth factor-dependent proliferation events in mammalian development by both derepressing several classes of repressors and by activating Pitx2, regulating the activity of several growth control genes.


Asunto(s)
Fase G1/genética , Proteínas de Homeodominio/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Factores de Transcripción/metabolismo , Proteínas de Pez Cebra , Animales , Línea Celular , Neoplasias del Colon/genética , Neoplasias del Colon/metabolismo , Ciclina D1/metabolismo , Ciclina D2 , Ciclinas/metabolismo , Proteínas del Citoesqueleto/metabolismo , Fase G1/fisiología , Genes myc , Histona Desacetilasa 1 , Histona Desacetilasas/metabolismo , Humanos , Ratones , Ratones Noqueados , Proteínas Nucleares/metabolismo , Co-Represor 1 de Receptor Nuclear , Regiones Promotoras Genéticas , Proteínas Represoras/metabolismo , Transducción de Señal , Transactivadores/metabolismo , Células Tumorales Cultivadas , Proteínas Wnt , beta Catenina , Proteína del Homeodomínio PITX2
20.
Cell ; 111(5): 673-85, 2002 Nov 27.
Artículo en Inglés | MEDLINE | ID: mdl-12464179

RESUMEN

Understanding the cell type-specific molecular mechanisms by which distinct signaling pathways combinatorially control proliferation during organogenesis is a central issue in development and disease. Here, we report that the bicoid-related transcription factor Pitx2 is rapidly induced by the Wnt/Dvl/beta-catenin pathway and is required for effective cell-type-specific proliferation by directly activating specific growth-regulating genes. Regulated exchange of HDAC1/beta-catenin converts Pitx2 from repressor to activator, analogous to control of TCF/LEF1. Pitx2 then serves as a competence factor required for the temporally ordered and growth factor-dependent recruitment of a series of specific coactivator complexes that prove necessary for Cyclin D2 gene induction. The molecular strategy underlying interactions between the Wnt and growth factor-dependent signaling pathways in cardiac outflow tract and pituitary proliferation is likely to be prototypic of cell-specific proliferation strategies in other tissues.


Asunto(s)
Proteínas del Citoesqueleto/metabolismo , Proteínas de Homeodominio/metabolismo , Proteínas Nucleares , Organogénesis/genética , Proteínas/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Transducción de Señal , Transactivadores/metabolismo , Factores de Transcripción/metabolismo , Proteínas de Pez Cebra , Proteínas Adaptadoras Transductoras de Señales , Animales , División Celular , Línea Celular , Ciclina D2 , Ciclinas/metabolismo , Proteínas Dishevelled , Regulación del Desarrollo de la Expresión Génica , Corazón/embriología , Histona Desacetilasas/metabolismo , Ratones , Ratones Noqueados , Ratones Transgénicos , Modelos Biológicos , Fosfoproteínas , Hipófisis/embriología , Activación Transcripcional , Proteínas Wnt , beta Catenina , Proteína del Homeodomínio PITX2
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA